Michael C Van Zandt (Michael van Zandt)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

New England Discovery Partners

This page only lists publications with an associated author ORCID identifier.

Affiliation History

New England Discovery Partners Aug 15 2012

United States

President & CEO :: Chemistry

Publications

Jim Li, Lijing Chen, Roland J Billedeau, Timothy F Stanton, John T P Chiang, Clarissa C Lee, Weiqun Li, Susanne Steggerda, Ethan Emberley, Matthew Gross, Deepthi Bhupathi, Xiaoying Che, Jason Chen, Rosalyn Dang, Tony Huang, Yong Ma, Andrew MacKinnon, Amani Makkouk, Gisele Marguier, Silinda Neou, Natalija Sotirovska, Sandra Spurlock, Jing Zhang, Winter Zhang, Michael C Van Zandt, Lin Yuan, Jennifer Savoy, Francesco Parlati, Eric B Sjogren
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity. Journal of medicinal chemistry (2022)
Jim Li, Lijing Chen, Roland J Billedeau, Timothy F Stanton, John T P Chiang, Clarissa C Lee, Weiqun Li, Susanne Steggerda, Ethan Emberley, Matthew Gross, Deepthi Bhupathi, Xiaoying Che, Jason Chen, Rosalyn Dang, Tony Huang, Yong Ma, Andrew MacKinnon, Amani Makkouk, Gisele Marguier, Silinda Neou, Natalija Sotirovska, Sandra Spurlock, Jing Zhang, Winter Zhang, Michael C Van Zandt, Lin Yuan, Jennifer Savoy, Francesco Parlati, Eric B Sjogren
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity. Journal of medicinal chemistry 66 (1) (2022)
Jim Li, Lijing Chen, Roland J Billedeau, Timothy F Stanton, John T P Chiang, Clarissa C Lee, Weiqun Li, Susanne Steggerda, Ethan Emberley, Matthew Gross, Deepthi Bhupathi, Xiaoying Che, Jason Chen, Rosalyn Dang, Tony Huang, Yong Ma, Andrew MacKinnon, Amani Makkouk, Gisele Marguier, Silinda Neou, Natalija Sotirovska, Sandra Spurlock, Jing Zhang, Winter Zhang, Michael C Van Zandt, Lin Yuan, Jennifer Savoy, Francesco Parlati, Eric B Sjogren
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity. Journal of medicinal chemistry 66 (1) (2022)
Jim Li, Lijing Chen, Roland J Billedeau, Timothy F Stanton, John T P Chiang, Clarissa C Lee, Weiqun Li, Susanne Steggerda, Ethan Emberley, Matthew Gross, Deepthi Bhupathi, Xiaoying Che, Jason Chen, Rosalyn Dang, Tony Huang, Yong Ma, Andrew MacKinnon, Amani Makkouk, Gisele Marguier, Silinda Neou, Natalija Sotirovska, Sandra Spurlock, Jing Zhang, Winter Zhang, Michael C Van Zandt, Lin Yuan, Jennifer Savoy, Francesco Parlati, Eric B Sjogren
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity. Journal of medicinal chemistry 66 (1) (2022)
Michael C Van Zandt, G Erik Jagdmann, Darren L Whitehouse, Minkoo Ji, Jennifer Savoy, Olga Potapova, Alexandra Cousido-Siah, Andre Mitschler, Eduardo I Howard, Anna Marie Pyle, Alberto D Podjarny
Discovery of N-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and II. Journal of medicinal chemistry 62 (17) (2019)

Michael C Van Zandt.css-eqlu8i{font-size:small;padding-left:4px;} (Michael van Zandt)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael C Van Zandt (Michael van Zandt)